That additional genetic defects may be required to allow phenotypic output of PTEN-R173 defects is indicated by the observation that somatic cancers with PTEN-R173 variants have a range of co-occurring variants, including, but not limited to, oncogenic variants of PIK3CA or loss of second allele of PTEN (Fig. 3D). This evidence concerns the gene PTEN and cancer.